A new drug developed at Scripps Clinic and Research Foundation appears to be effective against hairy cell leukemia and may fight other types of blood cancer as well. In their study, doctors gave the drug to 12 patients. The drug, called PD-1 inhibitor, was discovered by researchers from the University of California, San Diego School of Medicine, who were studying a rare form of leukemia, which is caused when white blood cells are Two other drugs, interferon and deoxycoformycin, similar to 2-CdA, have been developed in recent years but interferon is less effective and both produce side effect. The only unwanted effect of 2-CdA was a few days of fever.
A new drug developed at Scripps Clinic and Research Foundation appears to be effective against hairy cell leukemia and may fight other types of blood cancer as well. The drug, called PD-1 inhibitor, was discovered by researchers from the University of California, San Diego School of Medicine, who were studying a rare form of leukemia, which is caused when white blood cells are Two other drugs, interferon and deoxycoformycin, similar to 2-CdA, have been developed in recent years but interferon is less effective and both produce side effect. The only unwanted effect of 2-CdA was a few days of fever.